Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib

Publication:
Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib

dc.contributor.author	Berna, Ronald
dc.contributor.author	Hasbún, María Trinidad
dc.contributor.author	Adams, Denise
dc.contributor.author	Moon, A.
dc.contributor.author	Treat, J. R.
dc.date.accessioned	2025-01-23T17:44:54Z
dc.date.available	2025-01-23T17:44:54Z
dc.date.issued	2024
dc.description.abstract	Giant congenital melanocytic nevi (GCMN) can be cosmetically significant and can lead to melanoma. There is no standard pharmacologic treatment for GCMN. We present the case of an 8-year-old female with kaposiform lymphangiomatosis caused by an NRAS mutation whose nevus spilus-type GCMN improved on oral selumetinib.
dc.description.version	Versión Aceptada
dc.identifier.citation	Berna R, Hasbun T, Adams D, Moon AT, Treat JR. Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib. Pediatr Dermatol. 2024 Sep-Oct;41(5):936-937. doi: 10.1111/pde.15666
dc.identifier.doi	https://doi.org/10.1111/pde.15666
dc.identifier.uri	https://hdl.handle.net/11447/9705
dc.language.iso	en
dc.title	Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib
dc.type	Article
dcterms.accessRights	Acceso Abierto
dcterms.source	Pediatric dermatology
dspace.entity.type	Publication
relation.isAuthorOfPublication	130e5d1d-fc50-489e-a30e-0683ee47e415
relation.isAuthorOfPublication.latestForDiscovery	130e5d1d-fc50-489e-a30e-0683ee47e415

Now showing 1 - 1 of 1

Name:: Significant improvement of a nevus spilus-type congenitalmelanocytic nevus with oral selumetinib.pdf
Size:: 681.32 KB
Format:: Adobe Portable Document Format
Description:: Texto Completo

Now showing 1 - 1 of 1